The Hungarian company Gedeon Richter began supplying Russia with three generics of foreign drugs used for type 2 diabetes: Januvia, Galvus and Galvus. These are funds of foreign pharmaceutical companies that have ceased their activities in the Russian Federation.
Deliveries of generics have already begun, but the company has not disclosed the volumes. Vedomosti’s requests to MSD and Novartis went unanswered.
After some foreign pharmaceutical companies announced a reduction in their investments in the Russian Federation in February 2022, their competitors had the opportunity to increase their share in the Russian market. However, local producers can compete with them here, according to experts.
Thus, domestic pharmaceutical companies Medisorb JSC and Grotex LLC (Solopharm) have regulatory certificates for the production of the generic Januvia, according to GRLS. And “Galvus”, according to the listing, may be produced by OA “Alium” and “Northern Star”.
- In March 2023, Russian scientists developed a device to monitor blood glucose levels without the need for punctures. A special glucometer is made in the form of a clip that is attached to the earlobe and measures sugar levels without having to prick them. The development itself is several years old, but now the company has launched its third crowdfunding for AnnNIGM 2, improving the original version of the device.
Author:
Karina Pardaeva
Source: RB
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
